Research on a New Intelligent Mobile Screening and Diagnosis Pattern for Ocular Diseases
- Conditions
- Ophthalmic Diseases (Specific Types Not Restricted)CataractRefraction ErrorDiabetic Retinopathy (DR)Age Related Macular Degeneration (ARMD)
- Registration Number
- NCT07003165
- Brief Summary
The global distribution of primary ophthalmic medical resources is uneven, and the traditional eye disease screening model has problems such as low efficiency, high cost and limited coverage. With the development of artificial intelligence and other technologies, it provides technical support for the construction of intelligent mobile screening model for eye diseases. The investigator's team has developed the 5G intelligent ophthalmic vehicle and served tens of thousands of people in 108 cities nationwide, initially verifying the feasibility of the new intelligent mobile screening model. However, the application effect, acceptance and influencing factors of this model in different regions are not clear, and there is a lack of economic benefit analysis based on real-world data. In this study, the investigators will conduct a cross-sectional study of large-scale population screening for blinding eye diseases in grassroots areas through the smart mobile screening model, focusing on the screening effectiveness and cost-effectiveness of the smart mobile screening model, integrating real-world multimodal eye health data, developing multiple smart screening analysis models, and exploring its adaptability and direction of improvement in grassroots areas.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 15000
- Age ≥ 7 years
- Voluntary informed consent
-Inability to complete the required examinations with the help of others due to old age, infirmity, poor general condition, etc.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cost-effectiveness Baseline,6months,12months Incremental Cost per True Positive Case Detected
- Secondary Outcome Measures
Name Time Method Eye disease detection rate Baseline,6months,12months Accuracy of multiple intelligent screening analysis models Baseline Screening participation rate baseline